Galderma Group AG Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	4,656	4,410	4,082	3,760	3,417
Other Revenue	34	30	35	63.6	28.1
Revenue	4,690	4,440	4,117	3,824	3,445
Revenue Growth (YoY)	8.62%	7.85%	7.66%	11.00%	-
Cost of Revenue	1,444	1,355	1,232	1,194	1,034
Gross Profit	3,246	3,085	2,885	2,630	2,411
Selling, General & Admin	2,264	2,151	1,990	1,908	1,711
Research & Development	229	260	287	315.9	342.6
Other Operating Expenses	10	3	2	5.1	7.7
Operating Expenses	2,503	2,414	2,279	2,229	2,062
Operating Income	743	671	606	400.9	349.5
Interest Expense	-214	-352	-561	-398.4	-352.7
Interest & Investment Income	14	12	6	-	-
Currency Exchange Gain (Loss)	-1	-11	-29	4.8	72.5
Other Non Operating Income (Expenses)	-21	16	31	12.9	-72.8
EBT Excluding Unusual Items	521	336	53	20.2	-3.5
Merger & Restructuring Charges	-16	-15	-17	-33.2	-38
Asset Writedown	-9	-	-1	-15.2	-19
Legal Settlements	-11	-11	-24	-23.7	-19.1
Pretax Income	485	310	11	-51.9	-79.6
Income Tax Expense	107	79	68	45	4.6
Earnings From Continuing Operations	378	231	-57	-96.9	-84.2
Earnings From Discontinued Operations	-	-	-	-1.6	-72
Net Income to Company	378	231	-57	-98.5	-156.2
Minority Interest in Earnings	-	-	-	-	1.9
Net Income	378	231	-57	-98.5	-154.3
Net Income to Common	378	231	-57	-98.5	-154.3
Shares Outstanding (Basic)	237	238	238	5,188	5,188
Shares Outstanding (Diluted)	238	238	238	5,188	5,188
Shares Change (YoY)	0.11%	0.10%	-95.42%	-	-
EPS (Basic)	1.59	0.97	-0.24	-0.02	-0.03
EPS (Diluted)	1.59	0.97	-0.24	-0.02	-0.03
Free Cash Flow	844	360	44	9.7	145.8
Free Cash Flow Per Share	3.55	1.51	0.18	0.00	0.03
Gross Margin	69.21%	69.48%	70.08%	68.77%	69.99%
Operating Margin	15.84%	15.11%	14.72%	10.48%	10.14%
Profit Margin	8.06%	5.20%	-1.39%	-2.58%	-4.48%
Free Cash Flow Margin	18.00%	8.11%	1.07%	0.25%	4.23%
EBITDA	984	891	818	630	567.3
EBITDA Margin	20.98%	20.07%	19.87%	16.48%	16.47%
D&A For EBITDA	241	220	212	229.1	217.8
EBIT	743	671	606	400.9	349.5
EBIT Margin	15.84%	15.11%	14.72%	10.48%	10.14%
Effective Tax Rate	22.06%	25.48%	618.18%	-	-

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.